IL1B and COVID-19: The SARS-CoV-2 spike (S) protein, known for its role in binding with the cell surface receptor ACE2, has been shown to activate the NLRP3 inflammasome and trigger IL-1β release from both macrophages and microglia derived from COVID-19 patients and healthy donors through TLR2-mediated signaling [94,95].